Jesper Stentoft
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 41
- Chronic Myeloid Leukemia Treatments 28
- Acute Myeloid Leukemia Research 11
- Platelet Disorders and Treatments 7
- Genetics 29
- Chronic Lymphocytic Leukemia Research 23
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Peter Hokland (4 shared papers)Susanne Saußele (11 shared papers)Francis J. Giles (9 shared papers)Eibhlin Conneally (10 shared papers)Andreas Hochhaus (11 shared papers)Valentín García‐Gutiérrez (8 shared papers)Norbert Gattermann (11 shared papers)Tamás Masszi (9 shared papers)
In The Last Decade
Jesper Stentoft
47 papers receiving 954 citations
Peers
Comparison fields: 5 of 67
- Hematology 780
- Genetics 534
- Rheumatology 283
- Oncology 208
- Public Health, Environmental and Occupational Health 127
Countries citing papers authored by Jesper Stentoft
This map shows the geographic impact of Jesper Stentoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper Stentoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper Stentoft more than expected).
Fields of papers citing papers by Jesper Stentoft
This network shows the impact of papers produced by Jesper Stentoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper Stentoft. The network helps show where Jesper Stentoft may publish in the future.
Co-authors
The 25 scholars most cited alongside Jesper Stentoft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 203 | |
| 2 | 2018 | 104 | |
| 3 | 2017 | 96 | |
| 4 | 1990 | 74 | |
| 5 | 2016 | 49 | |
| 6 | 2021 | 47 | |
| 7 | 2001 | 45 | |
| 8 | 2005 | 42 | |
| 9 | 2017 | 38 | |
| 10 | 2002 | 37 | |
| 11 | All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy. | 1994 | 22 |
| 12 | 2019 | 21 | |
| 13 | 2017 | 19 | |
| 14 | 1988 | 18 | |
| 15 | 2015 | 18 | |
| 16 | 1992 | 16 | |
| 17 | 2004 | 13 | |
| 18 | 2012 | 12 | |
| 19 | 1987 | 12 | |
| 20 | 2016 | 8 |
About Jesper Stentoft
Jesper Stentoft is a scholar working on Hematology, Genetics, Rheumatology, Oncology and Public Health, Environmental and Occupational Health, having authored 52 papers that have together received 974 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (28 papers), Chronic Lymphocytic Leukemia Research (23 papers), Eosinophilic Disorders and Syndromes (12 papers), Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (7 papers), Platelet Disorders and Treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Hematology (780 citations), Genetics (534 citations), Rheumatology (283 citations), Oncology (208 citations) and Public Health, Environmental and Occupational Health (127 citations). Jesper Stentoft has collaborated with scholars based in Denmark, Germany and Italy. Frequent co-authors include Peter Hokland, Susanne Saußele, Francis J. Giles, Eibhlin Conneally, Andreas Hochhaus, Valentín García‐Gutiérrez, Norbert Gattermann, Tamás Masszi, Jerald P. Radich and David M. Ross. Their work appears in journals such as Blood, European Journal Of Haematology, Leukemia, British Journal of Haematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.